255 related articles for article (PubMed ID: 28453853)
1. Single-Molecule Sequencing Revealing the Presence of Distinct JC Polyomavirus Populations in Patients With Progressive Multifocal Leukoencephalopathy.
Seppälä H; Virtanen E; Saarela M; Laine P; Paulín L; Mannonen L; Auvinen P; Auvinen E
J Infect Dis; 2017 Mar; 215(6):889-895. PubMed ID: 28453853
[TBL] [Abstract][Full Text] [Related]
2. New sequence polymorphisms in the outer loops of the JC polyomavirus major capsid protein (VP1) possibly associated with progressive multifocal leukoencephalopathy.
Zheng HY; Takasaka T; Noda K; Kanazawa A; Mori H; Kabuki T; Joh K; Oh-Ishi T; Ikegaya H; Nagashima K; Hall WW; Kitamura T; Yogo Y
J Gen Virol; 2005 Jul; 86(Pt 7):2035-2045. PubMed ID: 15958683
[TBL] [Abstract][Full Text] [Related]
3. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
4. JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route.
Van Loy T; Thys K; Ryschkewitsch C; Lagatie O; Monaco MC; Major EO; Tritsmans L; Stuyver LJ
J Virol; 2015 Jan; 89(2):1340-7. PubMed ID: 25392214
[TBL] [Abstract][Full Text] [Related]
5. JC Polyomavirus Whole Genome Sequencing at the Single-Molecule Level Reveals Emerging Neurotropic Populations in Progressive Multifocal Leukoencephalopathy.
L'Honneur AS; Pipoli Da Fonseca J; Cokelaer T; Rozenberg F
J Infect Dis; 2022 Sep; 226(7):1151-1161. PubMed ID: 34979561
[TBL] [Abstract][Full Text] [Related]
6. Archetype JC Polyomavirus (JCPyV) Prevails in a Rare Case of JCPyV Nephropathy and in Stable Renal Transplant Recipients With JCPyV Viruria.
Seppälä HM; Helanterä IT; Laine PKS; Lautenschlager IT; Paulín LG; Jahnukainen TJ; Auvinen POV; Auvinen E
J Infect Dis; 2017 Nov; 216(8):981-989. PubMed ID: 28968776
[TBL] [Abstract][Full Text] [Related]
7. JC polyomavirus: a short review of its biology, its association with progressive multifocal leukoencephalopathy, and the diagnostic value of different methods to manifest its activity or presence.
Prezioso C; Pietropaolo V; Moens U; Ciotti M
Expert Rev Mol Diagn; 2023 Feb; 23(2):143-157. PubMed ID: 36786077
[TBL] [Abstract][Full Text] [Related]
8. JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis.
Ciardi MR; Zingaropoli MA; Iannetta M; Prezioso C; Perri V; Pasculli P; Lichtner M; d'Ettorre G; Altieri M; Conte A; Pietropaolo V; Mastroianni CM; Vullo V
Virol J; 2020 Feb; 17(1):23. PubMed ID: 32046748
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the VP1 loop mutations widespread among JC polyomavirus isolates associated with progressive multifocal leukoencephalopathy.
Zheng HY; Ikegaya H; Takasaka T; Matsushima-Ohno T; Sakurai M; Kanazawa I; Kishida S; Nagashima K; Kitamura T; Yogo Y
Biochem Biophys Res Commun; 2005 Aug; 333(3):996-1002. PubMed ID: 15964545
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of highly pathogenic strains of human JC polyomavirus in neurological patients by next generation sequencing.
Auvinen E; Honkimaa A; Laine P; Passerini S; Moens U; Pietropaolo V; Saarela M; Maunula L; Mannonen L; Tynninen O; Haapasalo H; Rauramaa T; Auvinen P; Liimatainen H
J Clin Virol; 2024 Apr; 171():105652. PubMed ID: 38364704
[TBL] [Abstract][Full Text] [Related]
11. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
Shimbo E; Nukuzuma S; Tagawa YI
Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
[TBL] [Abstract][Full Text] [Related]
12. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
[TBL] [Abstract][Full Text] [Related]
13. Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?
Prezioso C; Zingaropoli MA; Iannetta M; Rodio DM; Altieri M; Conte A; Vullo V; Ciardi MR; Palamara AT; Pietropaolo V
Mult Scler Relat Disord; 2020 Jun; 41():102008. PubMed ID: 32087593
[TBL] [Abstract][Full Text] [Related]
14. Establishment of COS-JC cells persistently producing archetype JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Microbiol Immunol; 2018 Aug; 62(8):524-530. PubMed ID: 29932215
[TBL] [Abstract][Full Text] [Related]
15. Characterization of JC Polyomavirus Derived from COS-IMRb Cells.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Jpn J Infect Dis; 2021 Jan; 74(1):48-53. PubMed ID: 32741932
[TBL] [Abstract][Full Text] [Related]
16. Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.
Reid CE; Li H; Sur G; Carmillo P; Bushnell S; Tizard R; McAuliffe M; Tonkin C; Simon K; Goelz S; Cinque P; Gorelik L; Carulli JP
J Infect Dis; 2011 Jul; 204(2):237-44. PubMed ID: 21673034
[TBL] [Abstract][Full Text] [Related]
17. Analysis of variability of urinary excreted JC virus strains in patients infected with HIV and healthy donors.
Karalic D; Lazarevic I; Banko A; Cupic M; Jevtovic D; Jovanovic T
J Neurovirol; 2018 Jun; 24(3):305-313. PubMed ID: 29243131
[TBL] [Abstract][Full Text] [Related]
18. The JCPYV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML.
Rocca A; Martelli F; Delbue S; Ferrante P; Bartolozzi D; Azzi A; Giannecchini S
J Clin Virol; 2015 Sep; 70():1-6. PubMed ID: 26305810
[TBL] [Abstract][Full Text] [Related]
19. Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment.
Prezioso C; Grimaldi A; Landi D; Nicoletti CG; Brazzini G; Piacentini F; Passerini S; Limongi D; Ciotti M; Palamara AT; Marfia GA; Pietropaolo V
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578264
[TBL] [Abstract][Full Text] [Related]
20. Utility of droplet digital PCR for the quantitative detection of polyomavirus JC in clinical samples.
Giovannelli I; Ciccone N; Vaggelli G; Malva ND; Torricelli F; Rossolini GM; Giannecchini S
J Clin Virol; 2016 Sep; 82():70-75. PubMed ID: 27454232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
